Država: Avstralija
Jezik: angleščina
Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)
THIOMERSAL; BORDETELLA BRONCHISEPTICA (INACTIVATED CELL FREE EXTRACT
ZOETIS AUSTRALIA PTY LTD
vaccine - canine Bordetella(20ug/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
THIOMERSAL MERCURY Active 0.1 mg/ml; BORDETELLA BRONCHISEPTICA (INACTIVATED CELL FREE EXTRACT VACCINE-MICROBIAL Active 0.0 U
20 x 1mL; Syringe
VM - Veterinary Medicine
ZOETIS AUSTRALIA
DOG | BITCH | CASTRATE | PUPPY
IMMUNOTHERAPY
BORDETELLA SPP. | BORDETELLA BRONCHISEPTICA
Poison schedule: 0; Withholding period: WHP:NiL; Host/pest details: DOG: [BORDETELLA SPP.]; Poison schedule: 0; Withholding period: ; Host/pest details: DOG: [BORDETELLA SPP.]; For immunisation of dogs against Bordetella bronchiseptia infection, a contributing factor to the canine cough syndrome.Not to be used in dogs when they are: incubating an infectious disease; seriously debilitated by another infectious disease, parasitic infestation or malnutrition; or under treatment with immunosuppressive drugs.
Registered
2023-07-01
. ' APPENDIX 2 AUSTRALIAN GOVERNMENT AUSTRALIAN PESTICIDES AND VETERINARY MEDICINES AUTHORITY TEMPLATE FOR RELEVANT LABEL PARTICULARS (RLPS) (VETERINARY PRODUCTS) Select appropriate: [] New Product (include all applicable RLPs) OR 0 Variation (highlight instructions that are being varied). Approval no. of label being varied: 51774/0207. Signal heading: PRODUCT NAME: ACTIVE CONSTITUENVS: Statement of claims: Net contents: DIRECTIONS FOR USE Heading: RESTRAINTS: Contraindications: PRECAUTIONS: Side effects: RLP Approved Dosage & ADMINISTRATION: FOR ANIMAL TREATMENT ONLY CANVAC® 88 VACCINE Canvac BB Vaccine is an inactivated vaccine prepared from a cell-free extract of Bordetel/a bronchiseptica (20~g/mL). An aluminium salt is included to enhance the response to vaccination and to increase the duration of immunity. Thiomersal 0.1 mg/mL is added as a preservative. Canvac BB Vaccine is used for the immunisation of dogs against Bordetel/a bronchiseptica infection, a contributing factor to the canine cough syndrome. 20 x 1 mL dose syringes DIRECTIONS FOR USE READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT Contents must be left in outer package until immediately before use SHAKE GENTLY BEFORE USE N/A N/A This product should not be used ·in dogs when they are: 1. incubating an infectious disease; 2. seriously debilitated by another infectious disease, parasitic infestation or malnutrition; or 3. under treatment with immunosuppressive drugs. As Canvac BB Vaccine is an inactivated vaccine, untoward systemic effects are uncommon and the vaccine may be used in pregnant bitches. Careful palpation of the site of injection may reveal a small fibrous nodule in some dogs about a week after vaccination. This nodule will regress, becoming impalpable within two to six weeks. In a very few small, smooth-coated dogs a nodule may be visible for a limited period. Some animals may show transient post-vaccination reactions including injection site pain, lethargy and/or vomiting. Systemic allergic reactions such as anaphylaxis are thou Preberite celoten dokument
PRODUCT NAME: CANVAC™ BB VACCINE PAGE: 1 OF 5 THIS REVISION ISSUED: JANUARY, 2005 MATERIAL SAFETY DATA SHEET Issued by: Pfizer Australia Pty Ltd Phone: (02)9850 3333 SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY Pfizer Australia Pty Ltd 38-42 Wharf Road West Ryde NSW 2114 Tel: (02) 9850 3333 Fax: (02) 9850 3519 ____________________________________ PFIZER AUSTRALIA PTY LTD A.B.N. 50 008 422 348 SUBSTANCE: Bacterial cell extracts and other ingredients in buffered saline suspension. TRADE NAME: CANVAC™ BB VACCINE OTHER NAMES: _Bordetella bronchiseptica_ Vaccine PFIZER MSDS CODE: 0989 PRODUCT USE: For vaccination by injection of dogs against _Bordetella bronchiseptica_ (canine cough). CREATION DATE: MAY, 2004 REVISION DATE: DECEMBER, 2004 SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of NOHSC Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSDP CLASSIFICATION: None allocated (Aust), S2 (NZ). ADG CLASSIFICATION: None allocated. Not a Dangerous Good. UN NUMBER: None allocated. E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : White aqueous suspension. ODOUR: No odour. MAJOR HEALTH HAZARDS: No significant risk factors have been found for this product. P P P O O O T T T E E E N N N T T T I I I A A A L L L H H H E E E A A A L L L T T T H H H E E E F F F F F F E E E C C C T T T S S S INHALATION SHORT TERM EXPOSURE: Significant inhalation exposure is considered to be unlikely. Available data indicates that this product is not harmful. In addition product is unlikely to cause any discomfort or irritation. LONG TERM EXPOSURE: No data for health effects associated with long term inhalation. SKIN CONTACT: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. It s Preberite celoten dokument